DICEMBRINI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.834
EU - Europa 4.570
AS - Asia 3.215
SA - Sud America 599
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 82
OC - Oceania 51
Totale 16.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.710
RU - Federazione Russa 1.568
PL - Polonia 944
SG - Singapore 930
IT - Italia 928
CN - Cina 732
HK - Hong Kong 515
BR - Brasile 460
VN - Vietnam 382
IE - Irlanda 351
KR - Corea 241
SE - Svezia 210
FR - Francia 134
FI - Finlandia 120
DE - Germania 110
IN - India 88
CA - Canada 68
BD - Bangladesh 54
JO - Giordania 54
AR - Argentina 52
GB - Regno Unito 52
AU - Australia 50
ID - Indonesia 44
TR - Turchia 37
UA - Ucraina 36
EC - Ecuador 30
IQ - Iraq 29
JP - Giappone 28
CI - Costa d'Avorio 26
CH - Svizzera 25
MX - Messico 24
NL - Olanda 24
ES - Italia 19
ZA - Sudafrica 19
CO - Colombia 17
PK - Pakistan 14
HU - Ungheria 12
VE - Venezuela 11
JM - Giamaica 9
MA - Marocco 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
AZ - Azerbaigian 7
EG - Egitto 7
LT - Lituania 7
PT - Portogallo 7
PY - Paraguay 7
UZ - Uzbekistan 7
DZ - Algeria 6
SA - Arabia Saudita 6
AL - Albania 5
CR - Costa Rica 5
KZ - Kazakistan 5
NG - Nigeria 5
TH - Thailandia 5
TN - Tunisia 5
LV - Lettonia 4
MD - Moldavia 4
UY - Uruguay 4
HN - Honduras 3
IL - Israele 3
PA - Panama 3
PH - Filippine 3
PR - Porto Rico 3
TW - Taiwan 3
BE - Belgio 2
BH - Bahrain 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MM - Myanmar 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
TT - Trinidad e Tobago 2
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
EU - Europa 1
GP - Guadalupe 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
Totale 16.352
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.446
Warsaw 944
Ashburn 896
Singapore 692
Fairfield 682
Hong Kong 438
Dublin 351
Woodbridge 313
Seattle 298
Chandler 277
San Jose 276
Cambridge 274
Houston 258
Seoul 239
Wilmington 229
Beijing 202
Milan 166
Lawrence 138
Ho Chi Minh City 136
Altamura 135
Council Bluffs 121
Los Angeles 117
Florence 108
Princeton 107
Ann Arbor 104
Hefei 103
Moscow 103
Hanoi 84
Buffalo 82
Lauterbourg 74
Dallas 69
The Dalles 65
Rome 60
Boston 57
New York 57
Mumbai 52
Melbourne 49
Kent 47
Medford 47
Helsinki 45
San Diego 44
São Paulo 36
Boardman 35
Munich 34
Shanghai 34
Paris 33
Naples 30
Phoenix 30
Clifton 29
Jacksonville 28
Abidjan 26
Tokyo 26
Falls Church 25
Jakarta 24
Bern 21
Dong Ket 18
Orem 18
Rio de Janeiro 18
Turku 18
Bologna 17
Figino 17
Guangzhou 17
Montreal 17
Andover 16
Miano 16
Chicago 15
Redondo Beach 14
Baghdad 13
Quito 13
Atlanta 12
Frankfurt am Main 12
Izmir 12
Norwalk 12
San Francisco 12
Turin 12
Da Nang 11
Falkenstein 11
London 11
Toronto 11
Bari 10
Gyöngyös 10
Hillsboro 10
Shenzhen 10
Biên Hòa 9
Brasília 9
Charlotte 9
Dhaka 9
Porto Alegre 9
Ankara 8
Bengaluru 8
Bogotá 8
Catania 8
Denver 8
Fortaleza 8
Haiphong 8
Hải Dương 8
Johannesburg 8
Redwood City 8
Tianjin 8
Amman 7
Totale 10.919
Salva come PNG Salva come JPEG
Nome #
Use of ancient grains for the management of diabetes mellitus: A systematic review and meta-analysis 434
Adipokines as possible new predictors of cardiovascular diseases: a case control study. 353
3-iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mouse 348
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes. 331
“Persistente secrezione di Exendin-4, un agonista recettoriale del Glucagon-like peptide-1, mediante terapia genica mediata da Adeno-associated Viruses, su ghiandole salivari di roditori in due differenti modelli di obesità/diabete tipo 2” 314
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. 301
Psychopathology and continuous subcutaneous insulin infusion in type 1 diabetes 296
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. 253
The therapy of insulin resistance in other diseases besides type 2 diabetes. 243
Cardiovascular effects of basal insulins 235
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 230
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study 218
Effect of dipeptidyl-peptidase 4 inhibitors on circulating oxidative stress biomarkers in patients with type 2 diabetes mellitus 214
Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies 212
Hormonal signaling in biology and medicine 209
Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes 198
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 198
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials 197
Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies 195
Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. 192
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 192
Fasting and post-prandial glucose and diabetic complication. A meta-analysis 186
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 184
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials 177
Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review 176
Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance. 174
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 173
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 172
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 171
Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. 169
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 169
Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis 168
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) project 166
Bone: incretin hormones perceiver or receiver? 166
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: A meta-analysis of randomized clinical trials 164
Dipeptidyl peptidase-4 inhibitors and bone fractures: A meta-analysis of randomized clinical trials 163
Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies 162
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study) 161
From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy. 161
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials 161
Deprescription in elderly patients with type 2 diabetes mellitus 161
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 160
Periodontitis predicts HbA1c levels and glucose variability in type 1 diabetic patients: the PARODIA Florence Project study 159
Orthorexia nervosa and type 1 diabetes: results of a cross-sectional study 158
Orlistat and sibutramine beyond weight loss 157
A meta-analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes 157
combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in type 1 diabetes: A randomized cross‐over trial 157
Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge 156
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 155
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 155
Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies 154
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 154
Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists 153
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials 153
Safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of randomized clinical trials 151
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 150
Drugs for type 2 diabetes: Role in the regulation of bone metabolism 149
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. 148
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 146
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials 145
Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials 144
Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials 144
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism. 143
Cholelithiasis in patientes treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials 142
Predictors of efficacy of Sodium-GLucose Transporter-2 inhibitors and Glucagon-Like Peptide 1 receptor agonists: A retrospective cohort study 141
Cigarette Smoking as a Predictor of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Genital Infections: A Retrospective Cohort Study 141
Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials 139
Vitamin D therapy in adults with diabetes mellitus. 137
Plasma adiponectin and hyperglycaemia in diabetic patients 136
Correction to: Glucose control in diabetes during home confinement for the first pandemic wave of COVID‑19: a meta‑analysis of observational studies (Acta Diabetologica, (2021), 58, 12, (1603-1611), 10.1007/s00592-021-01754-2) 135
Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials 134
Measurement of body composition as a surrogate evaluation of energy balance in obese patients. 132
Correction to: Orthorexia nervosa and type 1 diabetes: results of a cross‑sectional study (Acta Diabetologica, (2023), 60, 5, (681-686), 10.1007/s00592-023-02044-9) 131
The impossible return to the Garden of Eden: The ORIGIN trial and the original sin of early insulin treatment of type 2 diabetes 130
Incretin-based therapies and cardiovascular risk 127
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 127
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 127
Inflammation markers and metabolic characteristic of subjects with one-hour plasma glucose levels 124
Is glucose control important for prevention of cardiovascular disease in diabetes? 124
Is there a practical way of predicting therapeutic success in type 2 diabetes on the basis of psychological features? Development and validation of the Psychological Predictors of Therapeutic success in Diabetes (PPTD) questionnaire 123
Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue? 122
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials 122
Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis. 120
Lipids seasonal variability in type 2 diabetes. 119
Diabetes as a risk factor for invasive meningococcal disease. A meta-analysis of observational studies 118
Erratum to: Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials (Acta Diabetologica, (2017), 54, 1, (19-36), 10.1007/s00592-016-0892-7) 118
Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support 116
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project 114
Glucose-lowering therapy in patients undergoing percutaneous coronary intervention 111
Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion 109
Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials 108
Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes. 107
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials 106
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials. 97
Le modificazioni dello stile di vita: curarsi o essere curato? 97
Fournier's gangrene and sodium-glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials 97
EFFECTS OF ANTIHYPERTENSIVE TREATMENTS ON INCIDENCE OF DIABETES: A CASE-CONTROL STUDY. 94
Sustained Exendin-4 secretion through gene therapy targeting salivary glands in Zucker fa/fa rats and high fat diet mice 88
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown 64
Validation of a New Test for Assessing the Quality of Life Perceived in Patients with Type 1 Diabetes 33
Totale 16.405
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.839
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022496 0 0 54 23 16 32 27 36 24 40 61 183
2022/20231.524 179 354 58 86 62 258 203 64 159 8 50 43
2023/2024569 24 61 98 28 34 48 19 103 13 55 66 20
2024/20254.264 147 425 340 618 1.161 622 92 278 211 110 130 130
2025/20265.057 489 697 421 466 619 185 538 245 293 276 168 660
2026/2027892 195 455 242 0 0 0 0 0 0 0 0 0
Totale 16.443